http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19419345

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Research Support, N.I.H., Extramural
endingPage 5554
issn 1557-3265
1078-0432
issueIdentifier 17
pageRange 5548-5554
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 5548
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e3d3f802664b3cb4aa7426d8e5d38ee8
bibliographicCitation de Bazelaire C, Alsop DC, George D, Pedrosa I, Wang Y, Michaelson MD, Rofsky NM. Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res. 2008 Sep 01;14(17):5548–54. doi: 10.1158/1078-0432.ccr-08-0417. PMID: 18765547.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2013ec8496c5e53739672ee0c3d2a822
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_000fd909cc13807c5ef194eae9417330
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b20b4b46298b85d847ab1a14210875d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab735a243579bff5fedc99742c7ca559
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4dcb7377cf67581641c39aac9ddc15a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b536ff9de4d896eb0e1198b0adf08626
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8678ea0b44116294de251d79868106f
date 2008-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1078-0432.ccr-08-0417
https://pubmed.ncbi.nlm.nih.gov/18765547
isPartOf https://portal.issn.org/resource/ISSN/1557-3265
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Magnetic Resonance Imaging–Measured Blood Flow Change after Antiangiogenic Therapy with PTK787/ZK 222584 Correlates with Clinical Outcome in Metastatic Renal Cell Carcinoma
discusses http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0016766
http://id.nlm.nih.gov/mesh/M0358615
http://id.nlm.nih.gov/mesh/M0018233
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002292Q000188
http://id.nlm.nih.gov/mesh/D007680Q000188
http://id.nlm.nih.gov/mesh/D011725Q000627
http://id.nlm.nih.gov/mesh/D007680Q000098
http://id.nlm.nih.gov/mesh/D020533Q000627
http://id.nlm.nih.gov/mesh/D002292Q000098
http://id.nlm.nih.gov/mesh/D010793Q000627
http://id.nlm.nih.gov/mesh/D008279Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009362
http://id.nlm.nih.gov/mesh/D002292Q000473
http://id.nlm.nih.gov/mesh/D005240
http://id.nlm.nih.gov/mesh/D007680Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D009389Q000188
http://id.nlm.nih.gov/mesh/D012039Q000187
http://id.nlm.nih.gov/mesh/D018450
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22386467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151193

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129776330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 57.